PGPC-d6
(Synonyms: 1-Palmitoyl-2-glutaryl Phosphatidylcholine-d6) 目录号 : GC47943A neuropeptide with diverse biological activities
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
PGPC-d6 is intended for use as an internal standard for the quantification of PGPC , as well as related fragmented short-chain fatty acid remnants of phospholipid oxidation, by GC- or LC-MS. PGPC is an oxidized phospholipid that can be formed under conditions of oxidative stress.1 It is found as a component in mildly oxidized LDL (MM-LDL) and in products formed from the oxidation of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (Ox-PAPC).2 PGPC activates peroxisome proliferator-activated receptor α (PPARα) in a concentration-dependent manner in a cell-based ligand-binding assay.3 It increases VCAM1 and E-selectin expression in human aortic endothelial cells (HAECs), as well as HAEC binding by monocytes and polymorphonuclear neutrophils (PMNs), in a concentration-dependent manner.4 PGPC (37.5 μM) also increases total 5-lipoxygenase metabolites in murine resident peritoneal macrophages (RPMs) and induces apoptosis in A7r5 rat aortic smooth muscle cells in vitro when used at a concentration of 50 μM.5,6 PGPC levels are increased in serum, LDL, and peripheral blood mononuclear cells (PBMCs) of patients with coronary artery disease.7 UVA irradiation increases PGPC levels in cultured human skin fibroblasts.8
1.Fruhwirth, G.O., Loidl, A., and Hermetter, A.Oxidized phospholipids: From molecular properties to diseaseBiochimica et Biophysica Acta1772718-736(2007) 2.Watson, A.D., Leitinger, N., Navab, M., et al.Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivoThe Journal of Biological Chemisty272(21)13597-13607(1997) 3.Lee, H., Shi, W., Tontonoz, P., et al.Role for peroxisome proliferator-activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cellsCirc. Res.87(6)516-521(2000) 4.Leitinger, N., Tyner, T.R., Oslund, L., et al.Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophilsProceedings of the National Academy of Sciences of the United States of America96(21)12010-12015(1999) 5.Zemski Berry, K.A., and Murphy, R.C.Phospholipid ozonation products activate the 5-lipoxygenase pathway in macrophagesChem. Res. Toxicol.29(8)1355-1364(2016) 6.Fruhwirth, G.O., Moumtzi, A., Loidl, A., et al.The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cellsBiochim. Biophys. Acta.1761(9)1060-1069(2006) 7.Mozzini, C., Frata Pasini, A., Garbin, U., et al.Increased endoplasmic reticulum stress and Nrf2 repression in peripheral blood mononuclear cells of patients with stable coronary artery diseaseFree Radic. Biol. Med.68178-185(2014) 8.Gruber, F., Bicker, W., Oskolkova, O.V., et al.A simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiationJ. Lipid. Res.53(6)1232-1242(2012)
Cas No. | N/A | SDF | |
别名 | 1-Palmitoyl-2-glutaryl Phosphatidylcholine-d6 | ||
Canonical SMILES | O=P(OCC[N+](C)(C)C)([O-])OC[C@H](OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C(O)=O)=O)COC(CCCCCCCCCCCCCCC)=O | ||
分子式 | C29H50D6NO10P | 分子量 | 615.8 |
溶解度 | DMSO: 1 mg/ml,Ethanol: 20 mg/ml,PBS (pH 7.2): 5 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.6239 mL | 8.1195 mL | 16.239 mL |
5 mM | 0.3248 mL | 1.6239 mL | 3.2478 mL |
10 mM | 0.1624 mL | 0.812 mL | 1.6239 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。